2021 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers

2021 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers

  • March 2021 •
  • Report ID: 4802787 •
  • Format: PDF
2021 Emerging Blood Typing, Grouping and NAT Screening Technologies, and Strategic Profiles of Leading Suppliers

This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking.

The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

Contains 114 pages



Companies Profiled

Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher